N
← Back to Search
Sponsored

Accelerate Your Clinical Trial Recruitment

Reach thousands of high-intent patients matching your specific inclusion criteria.

Start Campaign
RECRUITING Not applicable ClinicalTrials.gov

Argon Plasma Treatment for Ovarian Endometrioma Compared to Standard Cystectomy

Sponsor: Erbe Elektromedizin GmbH • ClinicalTrials.gov ID: NCT07065214

Registry updated: 2026-10-07
Ad

Recruiting for Similar Conditions?

Sponsors are looking for patients like you. See if you qualify for compensated research studies.

Check Eligibility →

Description

The study is a prospective, monocentric, randomized controlled, two-armed, pilot-study conducted at Department for Women's Health, Tuebingen, Germany. In this Post Market Study it will be determined whether and to what extent the two surgical procedures for ovarian endometrioma treatment (standard cystectomy versus APC) may affect the ovarian reserve by comparing changes in serum AMH levels after treatment. Seventy-two (72) patients who meet all eligibility criteria will undergo surgical procedure. The patients will be randomized into the group with standard cystectomy treatment or with APC treatment. Per group n=36 patients will be treated i.e., 1:1 randomization. A pre-specified primary endpoint analysis is planned after the last patient has undergo Visit 4 (Follow-up after 6 months) to analyze the primary endpoint. Screening takes place during the first visit (V1). During the second visit (V2) the participants will receive the ovarian endometriosis treatment procedure either with the APC or the standard cystectomy. Standard procedure (standard cystectomy) will be performed for additional endometriosis lesions. The follow up visits (V3 - V5) will take place after three, six and twelve months. Visit 3 and Visit 4 will take place at the study site and AMH will be measured. Whereas Visit 5 will take place via telemedical contact, i.e. phone call.

Interventions

  • APC (Device)
    For the surgical procedure for ovarian endometrioma treatment APCapplicator will be used
  • Lap bipolar forceps (Device)
    For ovarian endometrioma treatment the standard of care treatment will be performed.

Eligibility criteria

Inclusion Criteria: * Indication for surgical endometrioma treatment according to patient symptoms * Signed informed consent Exclusion Criteria: * Expected lack of patient compliance or inability of the patient to understand the purpose of the clinical trial * Prior procedures at the ovaries * Recurrent endometrioma (patients with recurrent endometriosis outside of the ovar, e.g. peritoneal endometriosis lesions can be included) * Pregnant or breastfeeding patients * Participation in any other clinical study that could affect the AMH level or pregnancy

Conditions

Endometriosis

Locations

  • Department for Women's Health — Tübingen, Germany, Germany
Sponsored

Partner with Nurenyx

Showcase your study to thousands of motivated patients matching your criteria.

Learn More

Official Source

Data sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

View Official Record